Wicki Andreas's Form 4 filing
Harmony Biosciences Holdings, Inc. (HRMY) · filed Nov 10, 2022
- Accession no.
- 0001104659-22-117342
- Filed
- Nov 10, 2022
- Trade date
- Nov 8-10, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $7.62M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Wicki AndreasCIK 0001511472 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 8, 2022 | Common Stock | SSaleDisposed | −18,865 | $60.01 | −$1,132,088.65 | 2,416,458 | Indirect | |
| Nov 9, 2022 | Common Stock | SSaleDisposed | −15,301 | $58.05 | −$888,223.05 | 2,401,157 | Indirect | |
| Nov 10, 2022 | Common Stock | SSaleDisposed | −95,242 | $58.80 | −$5,600,229.6 | 2,305,915 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.